Analysis Of Income And Expense [Abstract]

BioInvent International - Filing #678852

Concept 2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
Analysis of income and expense [abstract]
Revenue [abstract]
Revenue
71 461 SEK
326 126 SEK
Material income and expense [abstract]
Research and development expense
390 434 SEK
325 929 SEK
Finance income (cost)
39 842 SEK
8 418 SEK
Other operating income (expense)
1 379 SEK
739,000 SEK
Miscellaneous other operating expense
742,000 SEK
1 107 SEK
Selling, general and administrative expense [abstract]
Selling, general and administrative expense
51 606 SEK
50 750 SEK
Expenses by nature [abstract]
Expenses, by nature
441 403 SEK
377 047 SEK
Comprehensive income, continuing and discontinued operations [abstract]
Comprehensive income
330 304 SEK
330 304 SEK
42 503 SEK
42 503 SEK
Comprehensive income attributable to owners of parent, continuing and discontinued operations [abstract]
Comprehensive income, attributable to owners of parent
330 304 SEK
42 503 SEK

Talk to a Data Expert

Have a question? We'll get back to you promptly.